Market Tracker

12/17 6:05pm ET

Exelixis Inc (NASDAQ:EXEL)

During the Trading Day
1.36 +0.05 / +3.82%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
1.36 +0.0002 / +0.01%
 
Volume: 52.4K

Today’s Trading

Previous close1.31
Today’s open1.31
Day’s range1.29 - 1.37
Volume4,195,619
Average volume (3 months)2,741,708
Market cap$255.7M
Dividend yield--
Data as of 4:00pm ET, 12/17/2014

Growth & Valuation

Earnings growth (last year)-44.57%
Earnings growth (this year)-5.05%
Earnings growth (next 5 years)--
Revenue growth (last year)-33.96%
P/E ratioNM
Price/Sales36.00
Price/Book3.65

Competitors

 Today’s
change
Today’s
% change
BSTCBiospecifics Technol...+0.46+1.22%
ARWRArrowhead Research C...+0.23+3.92%
ENZEnzo Biochem Inc+0.51+12.44%
AMRNAmarin Corporation P...0.000.00%
Data as of 4:03pm ET, 12/17/2014

Financials

Next reporting dateFebruary 19, 2015
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$31.3M
Annual profit (last year)-$244.8M
Net profit margin-781.03%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Chief Financial Officer, Senior VP &
Controller
Deborah Burke
Corporate headquarters
South San Francisco, California

Forecasts